Vertex Pharmaceuticals · Operating Cash Flow (Statement)

Latest reported$4.29Bperiod endingJun 30, 2026

VRTX Cash from Operations (-$2.50M → $4.29B)

Annual operating cash flow (statement)

High-resolution chart · PNG

VRTX operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Dec 31, 2025	3,631,400,000
Dec 31, 2024	-492,600,000
Dec 31, 2023	3,537,300,000
Dec 31, 2022	4,129,900,000
Dec 31, 2021	2,643,500,000
Dec 31, 2020	3,253,505,000
Dec 31, 2019	1,569,330,000
Dec 31, 2018	1,270,286,000
Dec 31, 2017	844,942,000
Dec 31, 2016	236,103,000
Dec 31, 2015	-365,432,000
Dec 31, 2014	-513,199,000
Dec 31, 2013	-51,570,000
Dec 31, 2012	267,841,000
Dec 31, 2011	143,735,000
Dec 31, 2010	-635,442,000
Dec 31, 2009	-427,586,000
Dec 31, 2008	-226,482,000
Dec 31, 2007	-252,476,000
Dec 31, 2006	-22,475,000
Dec 31, 2005	-172,054,000
Dec 31, 2004	-142,160,000
Dec 31, 2003	-167,623,000
Dec 31, 2002	-79,539,000
Dec 31, 2001	-8,074,000
Dec 31, 2000	-16,644,000
Dec 31, 1999	-31,800,000
Dec 31, 1998	-31,100,000
Dec 31, 1997	-9,400,000
Dec 31, 1996	-40,300,000
Dec 31, 1995	-16,000,000
Dec 31, 1994	-14,700,000
Dec 31, 1993	8,600,000
Dec 31, 1992	-5,300,000
Dec 31, 1991	-2,500,000